Pay in 4 interest-free payments of $11.25 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
Curr Pharm Des
Theriault JR
1417353-16-2 (SCR7 E/S)
Self-renewal as a therapeutic target in human colorectal cancer
SBI-0206965 - Autophagy Kinase ULK1 Inhibitor. CAS# 1884220-36-3 0129 Curr Pharm DesSBI 0206965, CAS No. 1884220 36 3, is a potent and selective autophagy Kinase ULK1 Inhibitor. Many tumors become addicted to autophagy for survival, suggesting inhibition of autophagy as a potential broadly applicable cancer therapy. SBI 0206965 is a highly selective ULK1 kinase inhibitor in vitro and suppressed ULK1 mediated phosphorylation events in cells, regulating autophagy and cell survival. SBI 0206965 greatly synergized with mechanistic target
US$ 186.50
US$ 762.00
US$ 95.00
US$ 74.00
US$ 853.00
US$ 123.50
US$ 137.00
US$ 911.50
US$ 169.00
US$ 102.50
US$ 121.00
US$ 629.50
US$ 174.00
US$ 169.00
US$ 116.00
US$ 102.50
US$ 126.50
US$ 147.50
US$ 179.00